Anti-tumor metastatic activity of β-glucan purified from mutated Saccharomyces cerevisiae

International Immunopharmacology

Volumn 8, Issue 1, 2008, Pages 36-42

  Yoon, Taek Joon ^a,b,d   Kim, Tack Joong ^a,c,d   Lee, Hwa ^a,d   Shin, Kwang Soon ^c,d   Yun, Yeo Pyo ^c,d   Moon, Won Kook ^d,e   Kim, Dong Woo ^d,e   Lee, Kwang Ho ^a,d  

^a Konkuk University Glocal Campus   (South Korea)

^b Yuhan College   (South Korea)

^c Chungbuk National University   (South Korea)

^d Kyonggi University   (South Korea)

^e Natural F and P Co   (South Korea)

Author keywords

Cytokines; IS 2; Macrophage; Mutated Saccharomyces cerevisiae; NK cell; Tumor metastasis

Indexed keywords

BETA GLUCAN; CYTOKINE; GAMMA INTERFERON; GANGLIOTETRAOSYLCERAMIDE; INTERLEUKIN 12; INTERLEUKIN 1BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; ASSAY; CANCER CELL; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CANCER SURVIVAL; CELL ASSAY; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DOSE RESPONSE; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; IN VITRO SELECTION; IN VITRO STUDY; INNATE IMMUNITY; INOCULATION; LEUKEMIA L 5178 Y; LIVER METASTASIS; LUNG METASTASIS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; MACROPHAGE ACTIVATION; MELANOMA B16; MUTATION; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; SACCHAROMYCES CEREVISIAE; SPLEEN CANCER; SURVIVAL TIME; TUMOR GROWTH;

ANIMALS; BETA-GLUCANS; CELL LINE, TUMOR; COCULTURE TECHNIQUES; FEMALE; LEUKEMIA L5178; LUNG NEOPLASMS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MUTAGENESIS; RABBITS; SACCHAROMYCES CEREVISIAE;

EID: 36649038772     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2007.10.005     Document Type: Article

References (29)

1. Schepetkin I.A., Faulkner C.L., Nelson-Overton L.K., Wiley J.A., and Mark T.Q. Macrophage immunomodulatory activity of polysaccharides isolated from Juniperus scopolorum. Int Immunopharmacol 5 (2005) 1783-1799
2. Rubin H. The significance of biological heterogeneity. Cancer Metastasis Rev 9 (1990) 1-20
3. Schantz S.P., Brown B.W., Lira E., Taylor S.L., and Beddingfield N. Evidence for the role of natural immunity in the control of metastatic spread of head and neck cancer. Cancer Immunol Immunother 25 (1987) 141-148
4. Villinger F. Cytokines as clinical adjuvants: how far are we?. Expert Rev Vaccines 2 (2003) 317-326
5. Wasser S.P. Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Appl Microbiol Biotechnol 60 (2002) 258-274
6. Chino A., Sakurai H., Choo M.K., Koizumi K., Shimada Y., Terasawa K., et al. Juzentaihoto, a Kampo medicine, enhances IL-12 production by modulating Toll-like receptor 4 signaling pathways in murine peritoneal exudate macrophages. Int Immunopharmacol 5 (2005) 871-882
7. Azuma I., and Seya T. Development of immunoadjuvants for immunotherapy of cancer. Int Immunopharmacol 1 (2001) 1249-1259
8. Whitmore M.M., DeVeer M.J., Edling A., Oates R.K., Simons B., Lindner D., et al. Synergistic activation of innate immunity by double-stranded RNA and CpG DNA promotes enhanced antitumor activity. Cancer Res 64 (2004) 5850-5860
9. Schantz S.P., Brown B.W., Lira E., Taylor S.L., and Beddingfield N. Evidence for the role of natural immunity in the control of metastatic spread of head and neck cancer. Cancer Immunol Immunother 25 (1987) 141-148
10. Barlozzari T., Leonhardt J., Wiltrout R.H., Herberman R.B., and Reynolds C.W. Direct evidence for the role of LGL in the reduction of experimental metastasis. J Immunol 134 (1985) 2783-2789
11. Andreesen R., Scheibenbogen C., Brugger W., Krause S., Meerpohl H.G., Leser H.G., et al. Adoptive transfer of tumor cytotoxic macrophages generated in vitro from circulating monocytes: a new approach to cancer immunotherapy. Cancer Res 50 (1990) 7450-7456
12. Hunter C.A., Chizzonite R., and Remington J.S. IL-1 beta is required for IL-12 to induce production of IFN-gamma by NK cells. A role for IL-1 beta in the T cell-independent mechanism of resistance against intracellular pathogens. J Immunol 155 (1995) 4347-4354
13. Kayagaki N., Yamaguchi N., Nakayama M., Takeda K., Akiba H., Tsutsui H., et al. Expression and function of TNF-related apoptosis-inducing ligand on murine activated NK cells. J Immunol 163 (1999) 1906-1913
14. Trinchieri G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 13 (1995) 251-276
15. Estrada A., Yun C.H., Van Kessel A., Li B., Hauta S., and Laarveld B. Immunomodulatory activities of oat beta-glucan in vitro and in vivo. Microbiol Immunol 41 (1997) 991-998
16. Pelizon A.C., Kaneno R., Soares A., Meira D.A., and Sartori A. Immunomodulatory activities associated with beta-glucan derived from Saccharomyces cerevisiae. Physiol Res 55 (2005) 557-564
17. Di Luzio N.R., Williams D.L., McNamee R.B., Edwards B.F., and Kitahama A. Comparative tumor-inhibitory and anti-bacterial activity of soluble and particulate glucan. Int J Cancer 24 (1979) 773-779
18. Rodriguez A., Cuesta A., Ortuno J., Esteban M.A., and Meseguer J. Immunostimulant properties of a cell wall-modified whole Saccharomyces cerevisiae strain administered by diet to seabream (Sparus aurata L.). Vet Immunol Immunopathol 96 (2003) 183-192
19. Park J.H., Kang M.S., Kim H.I., Chung B.H., Lee K.H., and Moon W.K. Study on immuno-stimulating activity of β-glucan isolated from the cell wall of yeast mutant Saccharomyces cerevisiae IS2. Korean J Food Sci Technol 35 (2003) 488-492
20. Calton B.C., and Brown B.J. Gene mutation. Manual of methods for general bacteriology (1981), ASM, Washington DC USA 222-242
21. Kelly G, Edmund G. Process for glucan preparation and therapeutic uses of glucan. US Patent 6, 2001;242,594.
22. Zhao G., Kan J., Li Z., and Chen Z. Characterization and immunostimulatory activity of an (1→6)-a-d-glucan from the root of Ipomoea batatas. Int Immunopharmacol 5 (2005) 1436-1445
23. Yoon T.J., Yoo Y.C., Lee S.W., Shin K.S., Choi W.H., Hwang S.H., et al. Anti-metastatic activity of Acanthopanax senticosus extract and its possible immunological mechanism of action. J Ethnopharmacol 93 (2004) 247-253
24. Tanigawa K., Craig R.A., Stoolman L.M., and Chang A.E. Effects of tumor necrosis factor-alpha on the in vitro maturation of tumor-reactive effector T cells. J Immunother 23 (2000) 528-535
25. Baxevanis C.N., Voutsas I.F., Tsitsilonis O.E., Tsiatas M.L., Gritzapis A.D., and Papamichail M. Compromised anti-tumor responses in tumor necrosis factor-alpha knockout mice. Eur J Immunol 30 (2000) 1957-1966
26. Lee S.J., Saiki I., Hayakawa Y., Nunome S., Yamada H., and Kim S.H. Antimetastatic and immunomodulating properties of a new herbal prescription, Bojung-bangam-tang. Int Immunopharmacol 3 (2003) 147-157
27. Lasek W., Feleszko W., Golab J., Stoklosa T., Marczak M., Dabrowska A., et al. Antitumor effects of the combination immunotherapy with interleukin-12 and tumor necrosis factor alpha in mice. Cancer Immunol Immunother 45 (1997) 100-108
28. Markovic S.N., and Murasko D.M. Role of natural killer and T-cells in interferon induced inhibition of spontaneous metastases of the B16F10 L murine melanoma. Cancer Res 51 (1991) 1124-1128
29. Suzuki M., Arika T., Amemiya K., and Fujiwara M. Cooperative role of T lymphocytes and macrophages in anti-tumor activity of mice pretreated with schizophyllan (SPG). Jpn J Exp Med 52 (1982) 59-65